Form 4 · Filed Jun 8, 2026, 08:36 PM UTC
KROS/Keros Therapeutics, Inc.
Knowles Julius — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | S | sell | 2,625 | $11 | $28,166 | 10,958 |
Source: SEC EDGAR raw filing ↗ · Accession 0001808365-26-000004